MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
series c preferred...
$10,850K
Proceeds from sale of
asset held for sale
$3,000K
Cash flows provided
by financing...
$10,850K
Cash flows provided
by (used in)...
$2,998K
Canceled cashflow
$2K
Net increase in cash
and cash...
$487K
Canceled cashflow
$13,361K
Inventories
-$1,445K
Stock-based compensation
$951K
Reduction in the carrying
amount of right-of-use...
$730K
Accrued expenses and
other liabilities
$610K
Non-cash interest
expense
$491K
Depreciation and
amortization
$138K
Loss from
termination of operating...
-$19K
Purchases of property and
equipment
$2K
Net increase in cash
and cash...
$487K
Cash flows used in
operating activities
-$13,361K
Canceled cashflow
$4,384K
Net loss
-$10,536K
Accounts receivable
$1,907K
Prepaid expenses and
other assets
$1,728K
Change in fair value of
warrant liabilities
-$899K
Gain on sale of asset
held for sale
$700K
Other assets, related
party
$686K
Operating lease
liabilities
-$683K
Accounts payable,
related parties, net
-$533K
Allowance for credit
losses
-$69K
Accounts payable
-$2K
Realized/unrealized loss in
investment, related party
$2K
Back
Back
Cash Flow
source: myfinsight.com
Biofrontera Inc. (BFRIW)
Biofrontera Inc. (BFRIW)